The Role of Bone Scintigraphy and Parathyroid Scintigraphy on Multiple Osteolytic Lesions Which Misdiagnosed as Primary Bone Tumor (Giant Cell Tumor)

Authors

  • Nora A. Prasetyo Department of Nuclear Medicine and Theranostic Molecular Dr. Hasan Sadikin. General Hospital Bandung - Faculty of Medicine Universitas Padjadjaran Bandung
  • Budi Darmawan Department of Nuclear Medicine and Theranostic Molecular Dr. Hasan Sadikin. General Hospital Bandung - Faculty of Medicine Universitas Padjadjaran Bandung
  • Erwin Affandi Department of Nuclear Medicine and Theranostic Molecular Dr. Hasan Sadikin. General Hospital Bandung - Faculty of Medicine Universitas Padjadjaran Bandung
  • A. Hussein S. Kartamihardja Department of Nuclear Medicine and Theranostic Molecular Dr. Hasan Sadikin. General Hospital Bandung - Faculty of Medicine Universitas Padjadjaran Bandung

DOI:

https://doi.org/10.19166/med.v10i1.6993

Keywords:

Bone scintigraphy, Parathyroid scintigraphy, Multiple osteolytic lesions, Primary bone tumor, Giant cell tumor

Abstract

Brown tumor is a non-neoplastic lesion that resulting from abnormal bone metabolism. It can be manifest in prolonged or untreated hyperparathyroidism. The clinical symptoms, radiological and histopathological examination were similar with giant cell tumor and can be mimicking metastases; or even misdiagnosed with giant cell tumor and mistreated the patient. Biochemical examination of calcium levels and parathyroid hormone should be included in the routine assessment of patients with multiple osteolytic lesions. A multidiscipline approach is needed.Throughout this case report, we would like to report the important role of Nuclear Medicine and Molecular Theranostic imaging modality in 38-year-old male with multiple osteolytic lesions, which was first diagnosed as giant cell tumor and differential diagnosis bone metastases but turnout to be a metabolic bone disease (brown tumor) with parathyroid adenoma as etiology.

References

1. Molecular Imaging: The Requisites. 5th ed. Philadelphia: Elsevier; 2021; 75-124.

2. Ghostine B, Sebaaly A, Ghanem I. Multifocal metachronous giant cell tumor: case report and review of the literature. Case Rep Med. 2014;2014:678035. https://doi.org/10.1155/2014/678035

3. Morey V, Sankineani SR, Kumar R. Multifocal metachronous giant cell tumour in bilateral upper limb: a rare case presentation. Musculoskelet Surg. 2014;98(2):165-9. https://doi.org/10.1007/s12306-012-0223-2

4. Lalam R, Bloem JL, Noebauer-Huhmann IM, Wortler K, Tagliafico A, Vanhoenacker F, et al. ESSR Consensus Document for Detection, Characterization, and Referral Pathway for Tumors and Tumorlike Lesions of Bone. Semin Musculoskelet Radiol. 2017;21(5):630-47. https://doi.org/10.1055/s-0037-1606130

5. Panagopoulos A, Tatani I, Kourea HP, Kokkalis ZT, Panagopoulos K, Megas P. Osteolytic lesions (brown tumors) of primary hyperparathyroidism misdiagnosed as multifocal giant cell tumor of the distal ulna and radius: a case report. J Med Case Rep. 2018;12(1):176. https://doi.org/10.1186/s13256-018-1723-y

6. Gosavi S, Kaur H, Gandhi P. Multifocal osteolytic lesions of jaw as a road map to diagnosis of brown tumor of hyperparathyroidism: A rare case report with review of literature. J Oral Maxillofac Pathol. 2020;24(Suppl 1):S59-S66. https://doi.org/10.4103/jomfp.JOMFP_319_19

7. Elgazzar AH. Parathyroid Gland. Dalam: Elgazzar AH, editor. The Pathophysiologic Basis of Nuclear Medicine. 2nd ed. Verlag-Berlin Heidelberg: Springer; 2006; 222-37. https://doi.org/10.1007/978-3-540-47953-6_8

8. El Demellawy D, Davila J, Shaw A, Nasr Y. Brief Review on Metabolic Bone Disease. Acad Forensic Pathol. 2018;8(3):611-40. https://doi.org/10.1177/1925362118797737

9. Elgazzar AH. Diagnosis of Metabolic, Endocrine, and Congenital Bone Disease. Dalam: Elgazzar AH, editor. Orthopedic Nuclear Medicine;10.1007/978-3-319-56167-7. 2nd ed. Switzerland: Springer 2017; 101-45. https://doi.org/10.1007/978-3-319-56167-7_3

10. Elgazzar AH. Basic Sciences of Bone and Joint Diseases. Dalam: Elgazzar AH, editor. Orthopedic Nuclear Medicine;10.1007/978-3-319-56167-7. 2th ed. Verlag Berlin Heidelberg: Springer; 2017; 1-36. https://doi.org/10.1007/978-3-319-56167-7_1

11. O'Malley JP, Ziessman HA. Endocrine System. Dalam: Thrall JH, editor. Nuclear Medicine and Molecular Imaging: The Requisites 5th ed. Philadelphia: Elsevier; 2021;152-79.

Downloads

Published

2023-06-06

Issue

Vol. 11 No. 3 (2022): June

Section

Case Report

License

Authors who publish with this journal agree to the following terms:

1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-SA 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website). The final published PDF should be used and bibliographic details that credit the publication in this journal should be included.